Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03478462
Title Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Brain Cancer, Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectar Biosciences, Inc.
Age Groups: adult | child
Covered Countries USA | CAN

No variant requirements are available.